Over-the-counter products across the front-end are becoming a more and more important profit driver for independent pharmacy operators, Hamacher Resource Group and the Healthcare Distribution Management Association revealed as part of new research titled "Independent Pharmacy Shoppers: Who, What, and Why?"

The Food and Drug Administration has approved a Novartis drug for treating leukemia in children.

The Food and Drug Administration has approved a new use for a cancer drug made by Roche unit Genentech, the agency said.

A new study indicated that some parents may not be sufficiently concerned about misuse of narcotic painkillers by children and teenagers.

H. D. Smith announced the establishment of H. D. Smith Specialty Solutions, an organization structured to provide focus and alignment around specialty and traditional brand products, solutions and services.

While regulations for biosimilars work their way through the Food and Drug Administration, state governments are already looking at legislation concerning the substitution of biosimilars for their branded counterparts, according to a legal affairs blog focused on the FDA.

Boehringer Ingelheim Pharmaceuticals has enrolled the first patients in its late-stage trial of a treatment for hepatitis C, the drug maker said Thursday.

More than 5,000 medicines are under development, of which 70% are potentially the first of their class, according to a new report.

An advocacy group focused on a rare lung disorder is working with government authorities to educate patients about the need to get flu shots.

Specialty drug spend will surpass traditional drug spend by 2018 for commercial plan sponsors, according to a new study.

While replacing a single combination pill for HIV with generics would save the healthcare system money, it could also diminish the effectiveness of treatment, a new study suggests.